Company intelligence / Profile preview

ImThera Medical

San Diego, California, United Statesinvestor.livanova.com ↗

Ownership: Private
Development stage: Commercial

Overview

The aura6000 System demonstrated significant improvements in obstructive sleep apnea symptoms in earlier studies. The pivotal THN3 study was designed to support pre-market approval and showed encouraging results for patients unable or unwilling to use PAP therapy.

Therapeutic areas: Pulmonology
Modalities: DeviceNeurostimulation device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on ImThera Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImThera Medical.

Explore the full profile